Tumor Microenvironment Surveillance on Simultaneous Liver Metastases Extensive Stage Small Cell Lung Cancer

Sponsor
Hunan Province Tumor Hospital
Study ID
NCT05055999
Status
Completed

Conditions

  • Extensive Stage Small Cell Lung Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of the trial is to detect tumor microenvironment on Extensive Stage Small Cell Lung Cancer with simultaneous liver metastases who Treated with Atezolizumab plus Etoposide and Platinum Based Chemotherapy.

Key Dates

First listed
Sep 24, 2021
Start date
Apr 1, 2019
Status verified
Apr 2019
Primary completion
Jul 1, 2021
Completion
Sep 1, 2021

Study Design

Enrollment
60 participants (actual)

Primary Outcome Measure

PFS [ Time Frame: April 2019- July 2021 ]

Related Studies